z-logo
open-access-imgOpen Access
Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease
Author(s) -
Sung-Yoon Jo,
Amandeep Bajwa,
Alaa S. Awad,
Kevin R. Lynch,
Mark D. Okusa
Publication year - 2008
Publication title -
kidney international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.499
H-Index - 276
eISSN - 1523-1755
pISSN - 0085-2538
DOI - 10.1038/ki.2008.34
Subject(s) - sphingosine 1 phosphate receptor , biology , sphingosine 1 phosphate , sphingolipid , sphingosine , fingolimod , receptor , microbiology and biotechnology , signal transduction , angiogenesis , pharmacology , immunology , cancer research , biochemistry , multiple sclerosis
The major sphingolipid metabolite, sphingosine-1-phosphate (S1P), has important biological functions. S1P is the ligand for a family of five G-protein-coupled receptors with distinct signaling pathways that regulate angiogenesis, vascular maturation, immunity, chemotaxis, and other important biological pathways. Recently, clinical trials have targeted S1P receptors (S1PRs) for autoimmune diseases and transplantation and have generated considerable interest in developing additional, more selective compounds. This review summarizes current knowledge on the biology of S1P and S1PRs that forms the basis for future drug development and the treatment of kidney disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom